prednimustine has been researched along with Thrombocytopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dombernowsky, P; Kristensen, D; Mouridsen, HT; Nielsen, JH | 1 |
| Barbarano, L; Bernuzzi, P; Gargantini, L; Morra, E; Nosari, A; Pungolino, E; Santoleri, L | 1 |
| Dusleag, J; Kasparek, AK; Lechner, P; Pfeiffer, K; Samonigg, H; Schmid, M; Smola, M; Steindorfer, P; Stöger, H | 1 |
3 other study(ies) available for prednimustine and Thrombocytopenia
| Article | Year |
|---|---|
Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chlorambucil; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Prednimustine; Psychoses, Substance-Induced; Thrombocytopenia; Time Factors; Vomiting | 1980 |
Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Prednimustine; Thrombocytopenia; Treatment Outcome | 2000 |
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Middle Aged; Mitoxantrone; Nausea; Prednimustine; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting | 1991 |